Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.

Autor: K, Kelley S, A, Harris L, D, Xie, L, Deforge, K, Totpal, J, Bussiere, A, Fox J

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; October 2001, Vol. 299 Issue: 1 p31-8, 8p